How to talk to your doctor about hormone therapy

The most useful thing you can do before this conversation is to arrive with a clear record of your symptoms, your health history, and a specific request. Hormone therapy is a shared decision that depends on facts only you can supply: how much your symptoms disrupt your life, whether you still have a uterus, and whether you or close relatives have had breast cancer, blood clots, stroke, or heart disease. Clinicians vary widely in menopause training, so knowing the framework they should be using helps you recognize a good answer and a poor one.

Before the visit

Log your symptoms for two weeks. Hot flashes per day, night sweats, how many times you wake, mood, cycle dates and flow. Our symptom check produces a one-page summary you can print or show on your phone.

Write down your history. The date of your last period, or your cycle pattern over the past year. Whether you have a uterus. Any history of breast or endometrial cancer, blood clots in a leg or lung, stroke, heart attack, or liver disease. Your family history of breast cancer, clots, heart disease, and osteoporosis. Every medication and supplement you take.

Decide what you want. “I want relief from night sweats so I can sleep” is a treatable request. “Something for menopause” invites a vague answer. If you have read about a specific option, such as an estradiol patch with micronized progesterone, say so.

Know the framework your clinician should use

Three points define current US guidance.

1. Age and timing. The Menopause Society and ACOG agree that for healthy women under 60 or within 10 years of menopause with bothersome symptoms, benefits generally outweigh risks. In November 2025 the FDA asked manufacturers to add the same consideration to hormone therapy labels and to remove the old instruction to use the lowest dose for the shortest time.
2. Contraindications, not age, decide eligibility. ACOG says systemic hormone therapy is usually not recommended if you have ever had breast or endometrial cancer, a stroke, a heart attack, blood clots, or liver disease. Everyone else is a candidate for a conversation.
3. Shared decision-making and review. ACOG advises talking every year about whether to continue. The Menopause Society says there is no fixed right time to stop.

Doses are still adjusted to the lowest that relieves your symptoms, and the full effect takes about 8 to 12 weeks, so a plan should include a follow-up on that timescale.

What to say

Keep it direct. Some openers that work:

• “My night sweats wake me three or four times a night and it is affecting my work. I would like to discuss hormone therapy.”
• “I have read that for someone my age the benefits usually outweigh the risks. Is there anything in my history that would change that?”
• “If you don’t prescribe hormone therapy, can you refer me to someone who does?”

If you are nervous, read from your notes. A written list is normal, and clinicians appreciate it.

Questions to ask

Question	Why it matters
Based on my history, am I a candidate for systemic hormone therapy?	Establishes eligibility first
Patch, gel, or pill: which do you recommend for me, and why?	Non-pill forms may lower clot risk; a reason should be given
I have a uterus: which progestogen, and cyclic or continuous?	Progestogens differ, and the bleeding pattern depends on the schedule
What dose are we starting with, and how will we adjust?	Full effect takes 8 to 12 weeks; a plan avoids giving up early
What side effects should I expect, and which should I call about?	Spotting, breast tenderness, and bloating are common early; new or heavy bleeding needs a call
When is our follow-up?	Should be within about 3 months
If hormone therapy is not right for me, what are the alternatives?	SSRIs and SNRIs, gabapentin, fezolinetant, and cognitive behavioral therapy are evidence-based
Do I still need contraception?	Hormone therapy is not birth control in perimenopause

What a good answer sounds like

A clinician comfortable with hormone therapy will name a specific estrogen and route, explain whether you need a progestogen and which one, set a starting dose, describe the bleeding and side effects to expect, and book a follow-up around 8 to 12 weeks. They will mention your personal risks and how the plan addresses them, for example choosing a patch because of your weight or a family history of clots.

A poor answer is a flat no without a reason, a reflexive “you’re too young” or “you’re too old,” or a referral to compounded “bioidentical” hormones or pellets. ACOG recommends FDA-approved hormone therapy over compounded products, which are not FDA-regulated and can vary in strength and purity.

If your clinician says no

Ask why. Legitimate reasons are the contraindications above, or an unresolved issue such as unexplained bleeding that needs evaluation first. If the reason is unfamiliarity, ask for a referral.

If hormone therapy is genuinely not an option for you, The Menopause Society’s 2023 nonhormone statement recommends, on the strongest evidence, cognitive behavioral therapy, clinical hypnosis, SSRIs or SNRIs, gabapentin, and fezolinetant, with oxybutynin on somewhat weaker evidence. It does not recommend supplements or herbal remedies, soy products, acupuncture, or clonidine, for lack of evidence of benefit. Paroxetine is a government-approved nonhormone option for hot flashes.

Why this is harder than it should be

Hormone therapy use in the United States collapsed after 2002 and never recovered. In a claims database of insured women aged 40 and older, systemic hormone therapy use fell from 4.4 percent in 2007 to 1.7 percent in 2023. Among women aged 50 to 59, the group most likely to have symptoms, use was about 3.5 percent in 2023. Many clinicians trained during those two decades saw few patients on hormone therapy. That is a reason to be persistent, not a reason to doubt yourself.

Finding someone with menopause training

The Menopause Society Certified Practitioner (MSCP) credential requires passing a competency exam and is renewed every 3 years. The Society’s Find a Menopause Practitioner directory lists its members and MSCPs with contact information and indicates who holds the credential; the Society suggests considering location, whether the practitioner offers telemedicine, and whether they accept your commercial insurance or Medicare. It also advises preparing a written list of questions and choosing someone who listens and respects your decisions.

Our guide on how to find a menopause specialist walks through the search, and our OB-GYN directory lists licensed clinicians by city.

After the visit

Start a new log. Note hot flashes, sleep, bleeding, and side effects, and bring it to the follow-up. Most adjustments are small: a dose change, a switch from pill to patch, or a different progestogen schedule. Give each change 8 to 12 weeks unless side effects are intolerable. If symptoms return after stopping, The Menopause Society notes that you and your clinician can reassess and restart; stopping is not a one-way door.